Literature DB >> 25998886

Preventive Effect of Cecropia pachystachya Against Ketamine-Induced Manic Behavior and Oxidative Stress in Rats.

Marta Gazal1, Fernanda N Kaufmann, Bruna A Acosta, Pathise Souto Oliveira, Matheus R Valente, Caroline Flach Ortmann, Régis Sturbelle, Claiton L Lencina, Francieli M Stefanello, Manuella P Kaster, Flávio Henrique Reginatto, Gabriele Ghisleni.   

Abstract

Cecropia species are widely used in traditional medicine by its anti-diabetic, anti-hypertensive and anti-inflammatory properties. In the present study, we investigated the neuroprotective and antioxidant effects of the crude aqueous extract from Cecropia pachystachya leaves in a rat model of mania induced by ketamine. The results indicated that ketamine treatment (25 mg/kg i.p., for 8 days) induced hyperlocomotion in the open-field test and oxidative damage in prefrontal cortex and hippocampus, evaluated by increased lipid peroxidation, carbonyl protein formation and decreased total thiol content. Moreover, ketamine treatment reduced the activity of the antioxidant enzymes superoxide dismutase and catalase in hippocampus. Pretreatment of rats with C. pachystachya aqueous extract (200 and 400 mg/kg p.o., for 14 days) or with lithium chloride (45 mg/kg p.o., for 14 days, used as a positive control) prevented both behavioral and pro-oxidant effects of ketamine. These findings suggest that C. pachystachya might be a useful tool for preventive intervention in bipolar disorder, reducing the episode relapse and the oxidative damage associated with the manic phase of this disorder .

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25998886     DOI: 10.1007/s11064-015-1610-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  Flavonoids and isoflavones: absorption, metabolism, and bioactivity.

Authors:  Catherine Rice-Evans
Journal:  Free Radic Biol Med       Date:  2004-04-01       Impact factor: 7.376

2.  Cardiotonic and sedative effects of Cecropia pachystachya Mart. (ambay) on isolated rat hearts and conscious mice.

Authors:  Alicia E Consolini; María Inés Ragone; Graciela N Migliori; Paula Conforti; María G Volonté
Journal:  J Ethnopharmacol       Date:  2006-01-18       Impact factor: 4.360

3.  Diphenyl diselenide ameliorates behavioral and oxidative parameters in an animal model of mania induced by ouabain.

Authors:  César Augusto Brüning; Marina Prigol; Cristiane Luchese; Simone Pinton; Cristina Wayne Nogueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-20       Impact factor: 5.067

4.  Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.

Authors:  Benício N Frey; Ana C Andreazza; Maurício Kunz; Fabiano A Gomes; João Quevedo; Mirian Salvador; Carlos Alberto Gonçalves; Flávio Kapczinski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-07-20       Impact factor: 5.067

5.  Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Authors:  Terence A Ketter; John P Houston; David H Adams; Richard C Risser; Adam L Meyers; Douglas J Williamson; Mauricio Tohen
Journal:  J Clin Psychiatry       Date:  2006-01       Impact factor: 4.384

6.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 7.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

8.  Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain.

Authors:  Patrícia S Brocardo; Josiane Budni; Eloísa Pavesi; Jeferson L Franco; Marcela Uliano-Silva; Rafael Trevisan; Mariana G Terenzi; Alcir L Dafre; Ana Lúcia S Rodrigues
Journal:  Bipolar Disord       Date:  2010-06       Impact factor: 6.744

9.  Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

Authors:  Rodrigo Machado-Vieira
Journal:  J Clin Psychopharmacol       Date:  2012-10       Impact factor: 3.153

10.  Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.

Authors:  Danielle M O Aragão; Lyvia Guarize; Juliana Lanini; Juliana C da Costa; Raúl M G Garcia; Elita Scio
Journal:  J Ethnopharmacol       Date:  2010-01-11       Impact factor: 4.360

View more
  5 in total

1.  Southern Brazilian native fruit shows neurochemical, metabolic and behavioral benefits in an animal model of metabolic syndrome.

Authors:  Pathise Souto Oliveira; Vitor Clasen Chaves; Mayara Sandrielly Pereira Soares; Natália Pontes Bona; Lorenço Torres Mendonça; Fabiano Barbosa Carvalho; Jessié Martins Gutierres; Flávia Aleixo Vasconcellos; Marcia Vizzotto; Andriele Vieira; Roselia Maria Spanevello; Flávio Henrique Reginatto; Claiton Leoneti Lencina; Francieli Moro Stefanello
Journal:  Metab Brain Dis       Date:  2018-06-07       Impact factor: 3.584

2.  Short-Term Ketamine Treatment Decreases Oxidative Stress Without Influencing TRPM2 and TRPV1 Channel Gating in the Hippocampus and Dorsal Root Ganglion of Rats.

Authors:  Arif Demirdaş; Mustafa Nazıroğlu; Ishak Suat Övey
Journal:  Cell Mol Neurobiol       Date:  2016-03-02       Impact factor: 5.046

3.  Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis.

Authors:  Zhi Ye; Qing Li; Qulian Guo; Yunchuan Xiong; Dong Guo; Hong Yang; Yan Shu
Journal:  Neuropharmacology       Date:  2017-09-28       Impact factor: 5.250

4.  Selection of chemical markers for the quality control of medicinal plants of the genus Cecropia.

Authors:  Andrés Rivera-Mondragón; Orlando O Ortíz; Sebastiaan Bijttebier; Arnold Vlietinck; Sandra Apers; Luc Pieters; Catherina Caballero-George
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 5.  Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase.

Authors:  Vânia Machado Recart; Luiza Spohr; Mayara Sandrielly Pereira Soares; Karina Pereira Luduvico; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2021-07-15       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.